Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.46 |
| ▸ | PRCP | P42785 | 8/20 | 0.45 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.43 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3280854 | 1.00 | CYP3A4 (0.52) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL13387183 | 0.92 | CYP3A4 (0.61) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL3812409 | 0.90 | CYP3A4 (0.45) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL4523180 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL3343766 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL4521947 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL3345373 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL3345359 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL3348029 | 0.86 | CYP3A4 (0.64) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 | |
| SCHEMBL1747004 | 0.85 | CYP3A4 (0.56) | CYP3A4CYP2C9NR1I2KCNH2ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2242750-A1 | CONFORMATIONALLY RESTRICTED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2010-10-27 | — | — | EP | claimed |
| US-7704992-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-04-27 | — | — | US | claimed |
| WO-2009102568-A1 | CONFORMATIONALLY RESTRICTED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-20 | — | — | WO | claimed |
| EP-2242750-B1 | CONFORMATIONALLY RESTRICTED BIPHENYL DERIVATIVES FOR USE AS HEPATITIS C VIRUS INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2013-04-24 | — | — | EP | disclosed |
| US-7704992-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-04-27 | — | — | US | disclosed |